Karenia cristata and Brevetoxins: The Human Health Dimension of South Australia’s Harmful Algal Bloom

By Sieglinde W. Alexander August 20, 2026

For much of 2025, South Australia’s extraordinary harmful algal bloom was primarily described as an ecological catastrophe. Fish, octopuses and other marine animals washed ashore dead, while large areas of coastline were affected by discoloured water and foam. Yet some of the earliest warning signs were not confined to the sea. People visiting affected beaches reported coughing, sore throats, irritated eyes and other respiratory symptoms.

Those human symptoms have become much more significant with the identification of a prime source of the bloom’s toxicity: the little-known dinoflagellate Karenia cristata.

Research published in Nature Ecology & Evolution in July 2026 showed that K. cristata dominated much of the complex Karenia assemblage associated with the South Australian event and, crucially, that cultured K. cristata produces substantial quantities of the neurotoxins BTX-2, BTX-3 and BTX-B5. The study linked the bloom to an affected area of about 20,000 square kilometres, deaths involving approximately one million marine animals from more than 600 taxa, and human-health impacts.

The discovery changes the way the event should be understood. This was not simply a marine wildlife disaster. Brevetoxins can move from microscopic algae through seawater into seafood and, remarkably, into the air. Humans therefore do not have to be marine animals—or even enter the water—to be exposed.

From a mystery bloom to a toxin-producing species

When the unusual mortality event became apparent around South Australia in 2025, scientists initially faced several possibilities. Harmful algal blooms can kill marine organisms through toxins, oxygen depletion, physical damage to gills or combinations of these mechanisms. Environmental conditions can also determine how intensely a bloom develops and where it accumulates.

By November 2025, researchers had narrowed down an important part of the mystery. Sampling indicated that several Karenia species were present, but Karenia cristata was generally dominant and appeared to be responsible for the brevetoxins detected during the event. At that stage the research was still undergoing peer review.

That conclusion became substantially stronger in July 2026 when the research was formally published. Scientists had isolated and cultured K. cristata and demonstrated that it produces substantial amounts of brevetoxins, with a toxin profile consisting principally of BTX-2, BTX-3 and BTX-B5.

This is scientifically important because K. cristata had been a poorly understood species. Brevetoxin toxicity is much better known from its relative Karenia brevis, the organism responsible for Florida’s notorious red tides. Consequently, much of what medicine knows about human exposure to brevetoxins comes from decades of research on K. brevis, rather than direct studies of South Australian K. cristata exposure.

That distinction matters. We now know that K. cristata produces brevetoxins, but we should not automatically assume that every dose-response relationship and every human-health effect established for K. brevis will be identical for K. cristata. Nevertheless, because the toxins themselves belong to the same brevetoxin family, the extensive human-health literature on K. brevis provides an important warning about what exposure can do.

Brevetoxins attack electrically excitable cells

Brevetoxins are potent neurotoxins whose effects arise from interference with voltage-gated sodium channels.

These channels are fundamental components of nerve and muscle cells. Normally they open and close in a tightly controlled fashion, allowing sodium ions to cross cell membranes and enabling electrical signals to travel through nerves and muscles. Brevetoxins bind to these channels and alter their behaviour, disrupting normal electrical signalling.

That mechanism helps explain an otherwise unusual combination of symptoms: brevetoxin exposure can affect the respiratory tract, nervous system and gastrointestinal system, depending on how a person encounters the toxin.

For the public, three exposure routes are particularly important: breathing contaminated marine aerosols, direct contact with bloom-affected water, and eating contaminated seafood.

The toxin can leave the sea

Perhaps the most important human-health feature of a brevetoxin-producing bloom is that exposure does not necessarily require swimming.

Waves and breaking surf can rupture toxin-containing algal cells and generate tiny seawater droplets. Brevetoxins can become incorporated into these marine aerosols and be carried inland by onshore winds. A person standing or walking on the beach can therefore inhale material originating from the bloom.

This phenomenon is well established during K. brevis red tides in Florida. Human exposure to aerosolised brevetoxins has been associated with coughing, sneezing, throat irritation, runny nose, eye irritation, wheezing and shortness of breath.

This makes brevetoxin fundamentally different from a hazard that remains confined to contaminated water.

A beach may therefore represent an inhalation exposure zone even when somebody never enters the ocean.

It also helps explain why reports of coughing and irritated eyes among South Australian beachgoers were scientifically important clues rather than merely secondary observations accompanying the marine mortality.

Asthma makes inhalation particularly important

People with asthma and other respiratory disorders deserve particular attention during brevetoxin-producing blooms.

Research involving people with physician-diagnosed asthma exposed for approximately one hour to Florida red-tide conditions found increased respiratory symptoms and measurable decreases in several measures of lung function following exposure. The effects were particularly apparent among participants regularly taking asthma medication.

Another study of 87 people with asthma found significantly increased respiratory symptoms following an hour of exposure to red-tide aerosols containing brevetoxins.

A 2024 review of 30 studies similarly concluded that aerosolised brevetoxin exposure is associated with respiratory-health effects and that exposure can compound existing respiratory problems.

For many healthy people, irritation caused by a brevetoxin aerosol may diminish after leaving the affected shoreline. That should not, however, lead to the conclusion that the airborne toxin is harmless. Susceptibility varies considerably, and people with asthma can experience substantially greater effects.

The critical point for South Australia is that the toxicology of K. cristata itself has only recently been established. Decades of Florida research provide strong evidence about what brevetoxins can do to humans, but the precise exposure thresholds and health risks associated specifically with K. cristata blooms still require investigation.

Direct contact with bloom water

A second route is direct recreational exposure.

The US Centers for Disease Control and Prevention notes that contact with water during brevetoxin-producing Karenia brevis blooms can be associated with eye irritation and skin rash, while breathing sea spray can produce coughing, sneezing, sore throat, shortness of breath and asthma attacks.

This means that swimming in a dense bloom potentially combines several exposures at once. A swimmer can have contaminated water against the skin and eyes while simultaneously inhaling aerosol generated by surf.

The presence of visible foam, discoloured water, dead animals or respiratory irritation among people nearby should therefore not be treated merely as an aesthetic problem with the beach.

Seafood creates a different form of exposure

The third major pathway is ingestion, and here brevetoxins present another unusual characteristic: the animal carrying the toxin does not necessarily have to appear obviously contaminated.

Filter-feeding shellfish such as mussels, oysters and scallops can accumulate brevetoxins from the water. Humans who subsequently eat contaminated shellfish can develop neurotoxic shellfish poisoning, or NSP.

Symptoms can include nausea, vomiting, diarrhoea and abdominal discomfort together with neurological effects such as numbness or tingling of the lips, mouth and throat and dizziness.

This combination of gastrointestinal and neurological symptoms reflects the fact that brevetoxin is a neurotoxin rather than simply a substance that irritates the digestive tract.

The seafood pathway also illustrates why the disappearance of visibly discoloured water does not by itself establish that seafood is safe. Public-health decisions depend on monitoring toxins and affected seafood, not merely looking at the ocean.

How dangerous is Karenia cristata to humans?

The answer requires some precision.

K. cristata should not be described as though an individual algal cell is lethally dangerous to anyone who encounters it. Human risk depends on the density of the bloom, toxin production, environmental conditions, duration of exposure, the route by which exposure occurs and the susceptibility of the individual.

At low background abundance, the practical risk may be very small. During a dense coastal bloom, however, the situation changes because enormous numbers of cells can collectively produce substantial quantities of toxin.

The July 2026 study demonstrated that K. cristata is capable of substantial brevetoxin production and described toxicological effects from the isolated organism. ABC subsequently reported the researchers' finding that laboratory-grown strains were highly toxic even at low concentrations.

For humans, risk can therefore be thought of as a continuum. Someone briefly near an unaffected stretch of coast faces a very different exposure from a person spending hours beside breaking surf during a dense onshore bloom. A person with asthma may be considerably more vulnerable to the latter exposure, while somebody consuming contaminated shellfish encounters an entirely different and potentially systemic dose.

This is why there is no scientifically defensible single answer such as “K. cristata is safe” or “K. cristata is deadly.” Concentration, exposure route and individual vulnerability matter.

The organism and the toxin are not the same environmental problem

Another important distinction is between the distribution of Karenia cells and the behaviour of the brevetoxins they produce.

K. cristata is a marine dinoflagellate and requires suitable environmental conditions to multiply into a bloom. But once toxin has been produced, scientists must separately consider what happens to that toxin: whether it remains dissolved or associated with cells and particles, how rapidly it degrades, whether currents transport it, whether organisms accumulate or transform it, and whether waves transfer it into aerosols.

In other words, asking “Where can Karenia cristata grow?” is not identical to asking “Where can brevetoxin exposure occur?”

The distinction becomes particularly important around coastlines, estuaries and beaches because humans can encounter different components of the bloom through different pathways.

A rare species with an unexpectedly wide significance

K. cristata was first formally described from South African waters, and before the South Australian event it was regarded as rare and poorly understood. The 2026 study has dramatically increased its significance because scientists have now demonstrated that this obscure species can be an important brevetoxin producer.

That does not mean K. cristata suddenly appeared in 2025 or that it recently became toxic. Rather, harmful algal species can persist at concentrations too low to attract attention and become conspicuous only when environmental and oceanographic conditions permit rapid population growth and accumulation.

It is also important not to reduce South Australia's event to a single species. The research identified a complex assemblage containing K. cristata and four other Karenia species whose abundances varied geographically and through time. K. cristata dominated across the sampling area and provides the strongest explanation for the brevetoxin component, but the overall ecological disaster resulted from a complex bloom.

The early human symptoms now make more sense

This is where the scientific progression from 2025 to 2026 becomes particularly revealing.

At the beginning of the event, scientists could observe the consequences: extraordinary marine mortality accompanied by foam, unusual water conditions and reports of respiratory and eye irritation among people on the coast. The environmental circumstances appeared favourable for a harmful algal bloom, but the responsible organisms and mechanisms remained uncertain.

By November 2025, researchers had identified K. cristata as the probable source of the brevetoxins.

By July 2026, culture experiments, chemical analyses, genetic characterization and toxicity assays had transformed that hypothesis into a much stronger scientific conclusion: the rare Karenia cristata is a substantial producer of BTX-2, BTX-3 and BTX-B5 and was a dominant component of the catastrophic South Australian bloom.

The coughing and eye irritation reported around affected beaches consequently acquire greater significance. They fit a well-established pattern of human exposure to aerosolised brevetoxins known from decades of research on Karenia brevis.

Search This Blog

Q and A: about health and research